Surgical technique of pleurectomy/decortication

Malignant pleural mesothelioma (MPM) is an aggressive and fatal thoracic malignancy associated with exposure to asbestos. Although there is no strong evidence to support how surgery can improve prognosis, multimodal therapy, including curative intent surgery, has been utilized in patients with resectable MPM. Two different approaches exist for curative intent surgery. Extrapleural pneumonectomy (EPP) is the well-established approach in which the lung is sacrificed with en bloc resection of the parietal pleura, ipsilateral lung, diaphragm, and pericardium. Pleurectomy/decortication (P/D) is the lung sparing surgery that involves the resection of parietal and visceral pleura. As neither EPP nor P/D obtain microscopic complete resection because of anatomical aspects, the goal of curative intent surgery for MPM is defined as macroscopic complete resection. This article describes the current status of P/D along with our observations. Regarding the surgical technique, which still remains considerably varied, our approach consists mainly of blunt dissection especially with cotton gloves or swabs. P/D is still a highly invasive surgery, though less so than EPP. Further reduction of invasiveness in the surgical approach is required to achieve better survival and postoperative quality of life.

[1]  S. Hasegawa,et al.  Surgical technique of pleurectomy/decortication , 2018 .

[2]  S. Tenconi,et al.  The management of the diaphragm during radical surgery for malignant pleural mesothelioma. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  R. Stahel,et al.  Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  S. Hasegawa,et al.  Current surgical strategies for malignant pleural mesothelioma , 2016, Surgery Today.

[5]  I. Opitz Management of malignant pleural mesothelioma-The European experience. , 2014, Journal of thoracic disease.

[6]  S. Hasegawa Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma , 2014, General Thoracic and Cardiovascular Surgery.

[7]  S. Bölükbas,et al.  Thoracic shaping technique to avoid residual space after extended pleurectomy/decortication. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  J. Friedberg The state of the art in the technical performance of lung-sparing operations for malignant pleural mesothelioma. , 2013, Seminars in thoracic and cardiovascular surgery.

[9]  W. Richards,et al.  Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. , 2013, The Journal of thoracic and cardiovascular surgery.

[10]  V. Rusch,et al.  The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. , 2013, The Journal of thoracic and cardiovascular surgery.

[11]  V. Rusch Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach. , 2012, Annals of cardiothoracic surgery.

[12]  D. Rice,et al.  Standardizing surgical treatment in malignant pleural mesothelioma. , 2012, Annals of cardiothoracic surgery.

[13]  C. Casadio,et al.  Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. , 2012, Lung cancer.

[14]  Keith Cengel,et al.  Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. , 2012, The Annals of thoracic surgery.

[15]  N. Tsubota,et al.  Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy , 2012, International Journal of Clinical Oncology.

[16]  V. Rusch,et al.  Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  B. Seifert,et al.  Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study. , 2011, The Journal of thoracic and cardiovascular surgery.

[18]  F. Galateau-Sallé,et al.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma , 2009, European Respiratory Journal.

[19]  F. Tanaka,et al.  Malignant mesothelioma: current status and perspective in Japan and the world , 2008, General thoracic and cardiovascular surgery.

[20]  V. Seshan,et al.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. , 2008, The Journal of thoracic and cardiovascular surgery.

[21]  D. Sugarbaker,et al.  Multimodality therapy for malignant pleural mesothelioma. , 1997, Chest.